⨯

working

Sign in

This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account

This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account


Sign In
Not a commercial user? Register here for our wider research bundle

More Content

More Content

Hybridan Small Cap Feast - 19 Jun 23

Companies: SCE FDBK IMM OTMP EVG TRP MMAG 8091

ImmuPharma 'now have clear regulatory path through to starting phase III trial for Lupuzor'

Companies: ImmuPharma plc

ImmuPharma "looking forward with quiet confidence" to FDA response

Companies: ImmuPharma plc

Most popular equity research this week | 7 - 11 Aug

Companies: PLI600258SQSFARNCSRTCTOAMSLGENSNXSUSDPHFA/EKFANCRIMMAGYCTHSPHRSCLPABCCNEKWSNAPSDNLBBSNEUSPVLGHZDBDRXFDMC4XDECSCPLUSTRMRHCMVERMXCTPPIXQRT

Hybridan Small Cap Feast - 18 May 23

Companies: OHG IDOX IMM SAR SRT MIRA NEXS GWMO KIBO

Copyright © 2023 Research Tree | All Rights Reserved. | Terms of Service and Privacy Policy and Statement on Cookies

Research Tree will never share your details with third parties for marketing purposes. Research Tree distributes research documents that have been produced and approved by Financial Conduct Authority (FCA) Authorised & Regulated firms as well as relevant content from non-authorised sources, who are not regulated but the information is in the public domain. For the avoidance of doubt Research Tree is not giving advice, nor has Research Tree validated any of the information.

Research Tree is an Appointed Representative of Sturgeon Ventures which is Authorised and Regulated by the Financial Conduct Authority.

Top